Triglav Skladi’s HCA Healthcare HCA Stock Holding History

Triglav Skladi’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,248	Closed	-$2.01M	–	191
2026 Q1	$2.01M	Buy	4,248 +2,100	+98%	+$1.06M	0.14%	90
2025 Q4	$1M	Buy	2,148 +148	+7%	+$68.7K	0.06%	130
2025 Q3	$852K	Buy	+2,000	New	+$775K	0.06%	122

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Triglav Skladi's HCA Position: Q2 2026 in Review

Triglav Skladi sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 4,248 shares — an estimated $2.01M sold.

Triglav Skladi first reported a position in HCA in Q3 2025 and held it in 3 quarters. The position peaked at $2.01M in Q1 2026. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Triglav Skladi reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
Triglav Skladi sold 4,248 HCA Healthcare shares in Q2 2026, an estimated $2.01M.
Triglav Skladi first reported a position in HCA Healthcare in Q3 2025 and held it in 3 quarters.
Triglav Skladi's HCA Healthcare position peaked at $2.01M in Q1 2026.
1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.